Targeting LL-37-Driven Psoriasiform Inflammation with Apolipoprotein A-I
Psoriasis is a chronic inflammatory skin disease characterized by dysregulated innate and adaptive immune responses. The antimicrobial peptide LL-37 is increased in psoriatic skin and can promote inflammation through effects on cellular damage, leukocyte recruitment, cytokine production, and the formation of immunostimulatory complexes with self-derived nucleic acids. Here, we investigated whether the human plasma protein apolipoprotein A-I (ApoA-I) can regulate LL-37 activity and thereby attenuate psoriasis-associated inflammation. We show that ApoA-I acts as a scavenger of LL-37 and that its administration confers therapeutic benefits in psoriatic skin, as demonstrated in an experimental animal model and human ex vivo models. Mechanistically, ApoA-I limited nucleic acid uptake and TLR-dependent type I interferon responses in plasmacytoid dendritic cells and keratinocytes. In an experimental mouse model, ApoA-I attenuated imiquimod-induced psoriasiform inflammation, reducing clinical, histological, and molecular disease features, while also suppressing inflammatory mediators and psoriasis-associated biomarkers in a human 3D psoriatic skin model. Together, these findings identify ApoA-I as a previously unrecognized regulator of LL-37-driven skin inflammation and suggest that therapeutic strategies aimed at restoring or mimicking ApoA1´s LL-37-scavenging mechanisms may have potential for treatment of psoriasis and related inflammatory skin diseases.
Authors
- Alicia Wong (ORCID: https://orcid.org/0000-0002-6679-8436)
- Dorota Satała (ORCID: https://orcid.org/0000-0002-6233-6680)
- Maria Rąpała‐Kozik (ORCID: https://orcid.org/0000-0002-3225-7391)
- Dominik A. Kowalczyk (ORCID: https://orcid.org/0000-0001-9474-4489)
- Firdaus Samsudin (ORCID: https://orcid.org/0000-0003-2766-4459)
- Anna Gołda (ORCID: https://orcid.org/0000-0002-3813-4966)
- Karina Adamowicz
- Danuta Bryzek (ORCID: https://orcid.org/0000-0003-3221-9632)
- Joanna Kozieł (ORCID: https://orcid.org/0000-0003-3436-6425)
- Artur Schmidtchen (ORCID: https://orcid.org/0000-0001-9209-3141)
- Jan Potempa (ORCID: https://orcid.org/0000-0002-3600-7461)
- Peter Bond
Institutions
- Agency for Science, Technology and Research (SG)
- Jagiellonian University (PL)
- University of Louisville (US)
- Bioinformatics Institute (SG)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11783966/v1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- preprint